DR.REDDY'S LABORATORIES LTD. - Dr Reddys Laboratories Ltd reply to clarification sought by the exchange

	< Back
30 Jun 2015
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing in Financial Chronicle on June 30, 2015 titled "DRL pulls out drugs from US"<BR><BR>Dr Reddys Laboratories Ltd replied stating "We have initiated a voluntary recall of Divalproex. This has been done as an abundant precautionary measure by the Company, based on observations related to the products' dissolution specifications. The observations are being investigated at our end and we are confident of a satisfactory resolution at the earliest. Pending submission of the investigation report to the USFDA, we would not like to comment further at this stage.<BR><BR>The overall impact on the Company's financials of this development is expected to be quite insignificant."
View all announcements for DR.REDDY'S LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us